Brain mapping with magnetic stimulation in mild to moderate Alzheimer's disease
Part of Brain & nervous system clinical trials.
This study tests a new brain stimulation device that uses magnetic pulses to map and possibly improve brain function in people with mild to moderate Alzheimer's disease. It aims to see if this approach can help with memory and thinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 65 and 85 years old.
- You need a reliable care partner who can spend at least 10 hours per week with you and attend study visits.
- You must have a diagnosis of mild to moderate Alzheimer's disease, with memory decline for more than 6 months.
- If you take Alzheimer's medication (like donepezil, rivastigmine, or galantamine), your dose must be stable for at least 12 weeks before starting.
- You must not have a history of seizures, epilepsy, or any other major neurological condition (like Parkinson's or stroke).
- You must be able to have an MRI scan (no metal implants or severe claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a non-invasive magnetic brain stimulation technique can help improve memory in people with early Alzheimer's disease. It may be an option if you have mild cognitive impairment or mild dementia due to Alzheimer's and have had a positive blood test for Alzheimer's markers.
This trial tests whether a non-invasive magnetic brain stimulation treatment (TMS) can help people with mild to moderate Alzheimer's disease. You would receive the treatment and be monitored for safety and benefit.
This study tests whether a safe, non-invasive brain stimulation technique called TMS (transcranial magnetic stimulation) can help improve memory and thinking in people with dementia. By measuring your brain waves first, researchers hope to tailor the stimulation to your specific needs.
This study tests whether a new type of brain stimulation (called repetitive transcranial magnetic stimulation, or rTMS) with a larger coil can improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves multiple sessions of rTMS and MRI scans.
This trial is testing whether a non-invasive brain stimulation treatment, called transcranial magnetic stimulation (using magnetic fields to activate brain cells), can help improve memory and thinking in people with Alzheimer's disease. It is a potential option for those looking to explore additional treatment approaches.
This trial tests a new, noninvasive treatment that combines magnetic and electrical stimulation to target a specific brain network in people with mild Alzheimer's disease. It aims to slow memory decline and improve brain function.
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.